TROMBEX 75mg film-coated tablets ZENTIVA
clopidogrel Indicated for: prevention of atherothrombotic events
letter T · page 61
clopidogrel Indicated for: prevention of atherothrombotic events
clopidogrel Indicated for: prevention of atherothrombotic events
acenocoumarol Indicated for: prevention and treatment of thromboembolism
trometamol Indicated for: metabolic acidosis
tropicamide Indicated for: ophthalmic diagnosis; cycloplegia
S01FA06 Sensory organs | Mydriatics and cycloplegics | Anticholinergics
tropicamide Indicated for: ophthalmic diagnosis; cycloplegia
S01FA06 Sensory organs | Mydriatics and cycloplegics | Anticholinergics
tropicamide Indicated for: ophthalmic diagnosis; cycloplegia
S01FA06 Sensory organs | Mydriatics and cycloplegics | Anticholinergics
tropicamide Indicated for: ophthalmic diagnosis; cycloplegia
S01FA06 Sensory organs | Mydriatics and cycloplegics | Anticholinergics
tropicamide Indicated for: ophthalmic diagnosis; cycloplegia
S01FA06 Sensory organs | Mydriatics and cycloplegics | Anticholinergics
tropicamide Indicated for: ophthalmic diagnosis; cycloplegia
S01FA06 Sensory organs | Mydriatics and cycloplegics | Anticholinergics
meloxicam Indicated for: pain and inflammation
meloxicam Indicated for: pain and inflammation
troxerutine Indicated for: chronic venous insufficiency; capillary fragility
C05CA04 Cardiovascular system | Capillary stabilizing agents | Bioflavonoids
troxerutine Indicated for: chronic venous insufficiency; capillary fragility
C05CA04 Cardiovascular system | Capillary stabilizing agents | Bioflavonoids
troxerutine Indicated for: chronic venous insufficiency; capillary fragility
C05CA04 Cardiovascular system | Capillary stabilizing agents | Bioflavonoids
troxerutine Indicated for: chronic venous insufficiency; capillary fragility
C05CA04 Cardiovascular system | Capillary stabilizing agents | Bioflavonoids
troxerutine Indicated for: chronic venous insufficiency; capillary fragility
C05CA04 Cardiovascular system | Capillary stabilizing agents | Bioflavonoids
troxerutine Indicated for: chronic venous insufficiency; capillary fragility
C05CA04 Cardiovascular system | Capillary stabilizing agents | Bioflavonoids
troxerutine Indicated for: chronic venous insufficiency; capillary fragility
C05CA04 Cardiovascular system | Capillary stabilizing agents | Bioflavonoids
letrozole Indicated for: breast cancer